Protagonist Therapeutics PTGX Income Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| $46.02M-89.4% | $434.43M+624% | $60M+126% | $26.58M-2.8% | ||
| $159.29M+15.3% | $138.13M+15.0% | $120.16M-4.8% | $126.22M+0.2% | ||
| $44.85M+3.2% | $43.46M+29.8% | $33.49M+5.5% | $31.74M+16.7% | ||
| $204.14M+12.4% | $181.59M+18.2% | $153.65M-2.7% | $157.95M+3.1% | ||
| $204.14M+12.4% | $181.59M+18.2% | $153.65M-2.7% | $157.95M+3.1% | ||
| -$158.13M-163% | $252.84M— | —— | -$131.37M-4.4% | ||
| -343.6%-402pp | 58.2%— | —— | -494.2%-34.2pp | ||
| $28.79M+9.4% | $26.32M+76.6% | $14.9M+267% | $4.06M+816% | ||
| —— | $250K— | —— | —— | ||
| -$129.31M-146% | $279.41M— | —— | -$127.39M-1.5% | ||
| $838K-80.1% | $4.22M— | —— | $0— | ||
| -$130.15M-147% | $275.19M— | —— | -$127.39M-1.5% | ||
| -282.8%-346pp | 63.3%— | —— | -479.3%-20.3pp | ||
| -$2.06-149% | $4.23— | —— | -$2.61+3.3% | ||
| -$2.06-146% | $4.50— | —— | -$2.61+3.3% | ||
| 253.8M+0.8% | 251.7M+12.7% | 223.3M+14.0% | 196M+6.8% | ||
| 253.8M+3.4% | 245.5M+9.9% | 223.3M+14.0% | 196M+6.8% | ||
| —— | $250K— | —— | —— | ||
| -$158.13M-163% | $252.84M— | —— | -$131.37M-4.4% | ||
| -$156.85M-162% | $253.67M— | —— | -$130.34M-4.2% | ||
| -$156.85M-162% | $253.67M— | —— | -$130.34M-4.2% | ||
| -340.9%-399pp | 58.4%— | —— | -490.3%-33.3pp | ||
| -$158.13M-163% | $252.84M— | —— | -$131.37M-4.4% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is Protagonist Therapeutics's revenue?
- Protagonist Therapeutics (PTGX) generated $74.1M in revenue over the trailing twelve months, down 64.4% year over year.
- Is Protagonist Therapeutics profitable?
- Protagonist Therapeutics is not currently profitable: it reported a net loss of $114.7M over the trailing twelve months, a -154.9% net margin.
- What is Protagonist Therapeutics's earnings per share?
- Protagonist Therapeutics's diluted EPS over the trailing twelve months is $-1.82.
- Where does Protagonist Therapeutics's income statement data come from?
- Every line is extracted from Protagonist Therapeutics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
